MGFA Scientific Session 2025

Myasthenia Gravis News is providing virtual coverage of the Myasthenia Gravis Foundation of America’s scientific session at the American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting taking place Oct. 29 in San Francisco. Stay tuned to this page for all the latest news.

October 29, 2025 News by Lindsey Shapiro, PhD

MGFA Session 2025: Vyvgart safe, effective in adolescents with gMG

Vyvgart (efgartigimod alfa-fcab), currently approved in the U.S. for treating certain adults with generalized myasthenia gravis (gMG), safely eased disease severity in adolescents with the disease, according to new data from a…

Read more

Recent Posts